These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20331467)

  • 1. Artificial contact pathway activation masks the haemostatic potential of rFVIIa and NN1731 in thrombocytopenic whole blood.
    Larsen OH; Ezban M; Persson E; Ingerslev J; Sørensen B
    Br J Haematol; 2010 Jul; 150(1):124-7. PubMed ID: 20331467
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
    Larsen OH; Clausen N; Persson E; Ezban M; Ingerslev J; Sørensen B
    Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
    Sørensen B; Persson E; Ingerslev J
    Br J Haematol; 2007 Apr; 137(2):158-65. PubMed ID: 17391496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B; Ingerslev J
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
    Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Barrett JC; Ezban M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):539-46. PubMed ID: 20581663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers.
    Johansson PI; Jacobsen N; Viuff D; Olsen EH; Rojkjaer R; Andersen S; Petersen LC; Kjalke M
    Br J Haematol; 2008 Nov; 143(4):559-69. PubMed ID: 18950467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.
    Gray LD; Hussey MA; Larson BM; Machlus KR; Campbell RA; Koch G; Ezban M; Hedner U; Wolberg AS
    Thromb Res; 2011 Dec; 128(6):570-6. PubMed ID: 21561645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats.
    Lauritzen B; Tranholm M; Ezban M
    J Thromb Haemost; 2009 Apr; 7(4):651-7. PubMed ID: 19175492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
    Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
    Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
    Sørensen B; Johansen P; Nielsen GL; Sørensen JC; Ingerslev J
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):469-77. PubMed ID: 12851533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of rFVIIa and NN1731 after intravenous administration to Beagle dogs.
    Agersø H; Kristensen NR; Østergaard H; Karpf DM; Hermit MB; Pelzer H; Petersen LC; Ezban M
    Eur J Pharm Sci; 2011 Apr; 42(5):578-83. PubMed ID: 21382491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
    Aljamali MN; Kjalke M; Hedner U; Ezban M; Tranholm M
    Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.
    Tranholm M; Rojkjaer R; Pyke C; Kristensen AT; Klitgaard B; Lollike K; Blajchman MA
    Thromb Res; 2003 Feb; 109(4):217-23. PubMed ID: 12757777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet membrane fragments enhance the procoagulant effect of recombinant factor VIIa in studies with circulating human blood under conditions of experimental thrombocytopenia.
    Tonda R; Galán AM; Mazzara R; White JG; Ordinas A; Escolar G
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):157-62. PubMed ID: 14872437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theragnostic performance of ex vivo testing of haemostatic intervention and clinical effect of recombinant factor VIIa and fibrinogen concentrate.
    Tang M; Wierup P; Christiansen K; Greisen J; Sørensen B
    Thromb Res; 2012 May; 129(5):e263-5. PubMed ID: 22475314
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats.
    Lauritzen B; Hedner U; Johansen PB; Tranholm M; Ezban M
    J Thromb Haemost; 2008 May; 6(5):804-11. PubMed ID: 18315554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA; Hoffman M; Roberts HR; Monroe DM
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the procoagulant action of recombinant activated factor VII in cord whole blood versus adult whole blood using thromboelastography.
    Koestenberger M; Gallistl S; Muntean W; Ferstl U; Kutschera J; Cvirn G
    Blood Coagul Fibrinolysis; 2005 Nov; 16(8):613-7. PubMed ID: 16269937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro analysis of the coagulation mechanism of activated factor VII using thrombelastogram.
    Kawaguchi C; Takahashi Y; Hanesaka Y; Yoshioka A
    Thromb Haemost; 2002 Nov; 88(5):768-72. PubMed ID: 12428092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.